<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01548794</url>
  </required_header>
  <id_info>
    <org_study_id>DiskapiTRHDYAZICIOGLU</org_study_id>
    <nct_id>NCT01548794</nct_id>
  </id_info>
  <brief_title>Recovery of Bupivacaine or Bupivacaine-Lidocaine Spinal Anesthesia and Infiltration Anesthesia in Herniorrhaphy</brief_title>
  <official_title>A Comparison of the Recovery Profiles of Bupivacaine or Bupivacaine Mixed With Lidocaine Spinal Anesthesia and Local Infiltration Anesthesia for Outpatient Herniorrhaphy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Teaching and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Teaching and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is the investigation of whether adding lidocaine to hyperbaric
      bupivacaine could decrease the duration of bupivacaine spinal block and provide shorter
      recovery and discharge times than local infiltration anesthesia in outpatient herniorrhaphy
      procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consecutive 93 patients undergoing inguinal herniorrhaphy will be recruited with a
      prospective protocol.Spinal anesthesia will be commenced in Group BLS with 2 ml hyperbaric
      bupivacaine (10 mg) + 0.6 ml 1 % lidocaine (6 mg), in Group BS, hyperbaric bupivacaine (10
      mg) + saline in the same volume and Group LIA will have anesthesia with bupivacaine and
      lidocaine for step by step local anesthetic infiltration. Sensorial block will be measured
      with pinprick test, motor block will be tested with Bromage scale. Heart rate, blood pressure
      and peripheral oxygen saturation will be measured every 5 minutes. Time of subarachnoid
      injection, onset of sensorial block (block at L1 dermatome), time to block T10 dermatome,
      maximum block level, time to maximum block and time to two segment regression, T10 regression
      , LI regression and S1 regression of the block will be recorded in group BLS and BS.The onset
      and resolution of the sensorial and motor block will be assessed by anesthetists blinded to
      group allocation. PACU stay and discharge times and VAS pain scores will be recorded in all
      patients. Patients also will be investigated for adverse events (hypotension, bradycardia,
      nausea,PDPH, TNS, urinary retention)and satisfaction regarding the anesthetic method.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of spinal block</measure>
    <time_frame>day of surgery</time_frame>
    <description>Time between the onset of the sensorial block at L1 dermatome and the resolution of the sensorial block at S3 dermatome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Discharge time</measure>
    <time_frame>Day of surgery</time_frame>
    <description>The time between the end of surgery and home discharge.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">93</enrollment>
  <condition>Anesthesia</condition>
  <condition>Inguinal Hernia</condition>
  <arm_group>
    <arm_group_label>Bupivacaine(Group B)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine+Lidocaine (Group BL)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local Infitration Anesthesia(Group LI)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>local infiltration anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>spinal anesthesia</intervention_name>
    <description>To receive 2 ml heavy bupivacaine + 0,6 ml saline</description>
    <arm_group_label>Bupivacaine(Group B)</arm_group_label>
    <other_name>marcaine heavy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>spinal anesthesia</intervention_name>
    <description>To receive 2ml bupivacaine +0,6 ml 1% lidocaine for spinal anesthesia.</description>
    <arm_group_label>Bupivacaine+Lidocaine (Group BL)</arm_group_label>
    <other_name>marcaine heavy</other_name>
    <other_name>lidocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>infiltration anesthesia</intervention_name>
    <description>To receive step by step local infiltration anesthesia as described by the Lichtenstein Institute.</description>
    <arm_group_label>Local Infitration Anesthesia(Group LI)</arm_group_label>
    <other_name>marcaine</other_name>
    <other_name>lidocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients having inguinal hernia

          -  Not hypersensitive to study drugs

          -  ASA classification I-III

        Exclusion Criteria:

          -  ASA classification IV-V

          -  Contraindications for spinal anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dilek Yazicioglu</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Diskapi Yildirim Beyazit Training and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06610</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Lee SJ, Bai SJ, Lee JS, Kim WO, Shin YS, Lee KY. The duration of intrathecal bupivacaine mixed with lidocaine. Anesth Analg. 2008 Sep;107(3):824-7. doi: 10.1213/ane.0b013e3181806149.</citation>
    <PMID>18713891</PMID>
  </reference>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2012</study_first_posted>
  <last_update_submitted>April 21, 2015</last_update_submitted>
  <last_update_submitted_qc>April 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Teaching and Research Hospital</investigator_affiliation>
    <investigator_full_name>DILEK YAZICIOGLU</investigator_full_name>
    <investigator_title>Doctor Specialist in Anesthesiology Principal investigator</investigator_title>
  </responsible_party>
  <keyword>spinal anesthesia</keyword>
  <keyword>bupivacaine</keyword>
  <keyword>lidocaine</keyword>
  <keyword>local infiltration anesthesia</keyword>
  <keyword>recovery</keyword>
  <keyword>duration of anesthesia</keyword>
  <keyword>outpatient herniorrhaphy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

